SS Innovations International (SSII) Free Cash Flow (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.84% |
| Dec 31, 2025 | 60.67% |
| Sep 30, 2025 | -118.17% |
| Jun 30, 2025 | 45.97% |
| Mar 31, 2025 | -105.98% |
| Dec 31, 2024 | -301.30% |
| Sep 30, 2024 | 73.07% |
| Jun 30, 2024 | -11.98% |
| Mar 31, 2024 | 38.08% |
| Dec 31, 2023 | 22.21% |
| Sep 30, 2023 | -98.67% |
| Jun 30, 2023 | -14.43% |
| Mar 31, 2023 | 9.93% |
| Dec 31, 2022 | -43.66% |
| Sep 30, 2022 | -76.25% |
| Jun 30, 2022 | -1,803.18% |
| Mar 31, 2022 | 48.61% |
| Dec 31, 2021 | 0.56% |
| Sep 30, 2021 | -112.49% |
| Jun 30, 2021 | 31.24% |
| Mar 31, 2021 | -1,232.48% |
| Dec 31, 2020 | 55.92% |
| Sep 30, 2020 | 35.53% |
| Jun 30, 2020 | 61.67% |
| Mar 31, 2020 | 42.77% |
| Dec 31, 2019 | 40.27% |
| Sep 30, 2019 | -324.77% |
| Jun 30, 2019 | 65.24% |
| Mar 31, 2019 | -13.99% |
| Dec 31, 2018 | 15.29% |
| Sep 30, 2018 | 9.33% |
| Jun 30, 2018 | 0.42% |
| Mar 31, 2018 | 17.37% |
| Dec 31, 2017 | -114.21% |
| Sep 30, 2017 | 41.63% |
| Jun 30, 2017 | -6.50% |
| Mar 31, 2017 | -90.37% |
| Dec 31, 2016 | 40.73% |